Australian medical cannabis producer Little Green Pharma recently became the first, and currently only, in its native country to bring locally-grown medical-grade products to market.

It is now plotting international growth, having recently exported medicinal cannabis products for patient use in the UK.

The firm was initially established to help a family access cannabis whose child was suffering up to 70 seizures a day, after the substance was legalised in Australia in late 2016.

The company quickly built a reputation and market presence through its first mover advantage and its vision to develop a precision dosing methodology, which effectively optimises the cannabis needed to be consumed to achieve the same results.

It recently raised $10m to fuel its expansion after listing on the Australian Securities Exchange (ASX), Little Green Pharma – the first business to ever export Australian medicinal cannabis – is now looking at global opportunities.

Earlier this month it entered the UK market after securing an import and distribution partnership with Astral Health, a subsidiary of the LYPHE Group.

Read the full article here: https://www.cannabishealthnews.co.uk/2020/04/24/big-plans-for-little-green-pharma/